168 related articles for article (PubMed ID: 33989083)
1. Neuregulin-1 compensates for endothelial nitric oxide synthase deficiency.
Shakeri H; Boen JRA; De Moudt S; Hendrickx JO; Leloup AJA; Jacobs G; De Meyer GRY; De Keulenaer GW; Guns PDF; Segers VFM
Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2416-H2428. PubMed ID: 33989083
[TBL] [Abstract][Full Text] [Related]
2. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
3. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury.
Yagi S; Akaike M; Aihara K; Ishikawa K; Iwase T; Ikeda Y; Soeki T; Yoshida S; Sumitomo-Ueda Y; Matsumoto T; Sata M
Hypertension; 2010 Apr; 55(4):918-23. PubMed ID: 20194307
[TBL] [Abstract][Full Text] [Related]
4. Endothelial nitric oxide synthase is predominantly involved in angiotensin II modulation of renal vascular resistance and norepinephrine release.
Stegbauer J; Kuczka Y; Vonend O; Quack I; Sellin L; Patzak A; Steege A; Langnaese K; Rump LC
Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R421-8. PubMed ID: 18046021
[TBL] [Abstract][Full Text] [Related]
5. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway.
Liu X; Wu J; Zhu C; Liu J; Chen X; Zhuang T; Kuang Y; Wang Y; Hu H; Yu P; Fan H; Zhang Y; Liu Z; Zhang L
J Cell Mol Med; 2020 Jan; 24(2):2013-2026. PubMed ID: 31854513
[TBL] [Abstract][Full Text] [Related]
6. Endothelial nitric oxide synthase of the bone marrow regulates myocardial hypertrophy, fibrosis, and angiogenesis.
Kazakov A; Müller P; Jagoda P; Semenov A; Böhm M; Laufs U
Cardiovasc Res; 2012 Mar; 93(3):397-405. PubMed ID: 22106415
[TBL] [Abstract][Full Text] [Related]
7. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression.
Flaherty MP; Brown M; Grupp IL; Schultz JE; Murphree SS; Jones WK
Cardiovasc Toxicol; 2007; 7(3):165-77. PubMed ID: 17901560
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin attenuates hypertrophy of neonatal rat cardiac myocytes induced by angiotensin-II in vitro.
Wen Y; Zhang XJ; Ma YX; Xu XJ; Hong LF; Lu ZH
Scand J Clin Lab Invest; 2009; 69(4):518-25. PubMed ID: 19347742
[TBL] [Abstract][Full Text] [Related]
9. Role of uncoupled endothelial nitric oxide synthase in abdominal aortic aneurysm formation: treatment with folic acid.
Gao L; Siu KL; Chalupsky K; Nguyen A; Chen P; Weintraub NL; Galis Z; Cai H
Hypertension; 2012 Jan; 59(1):158-66. PubMed ID: 22083158
[TBL] [Abstract][Full Text] [Related]
10. Renal cortical and medullary blood flow responses to L-NAME and ANG II in wild-type, nNOS null mutant, and eNOS null mutant mice.
Mattson DL; Meister CJ
Am J Physiol Regul Integr Comp Physiol; 2005 Oct; 289(4):R991-7. PubMed ID: 15961532
[TBL] [Abstract][Full Text] [Related]
11. HSF1 deficiency accelerates the transition from pressure overload-induced cardiac hypertrophy to heart failure through endothelial miR-195a-3p-mediated impairment of cardiac angiogenesis.
Wang S; Wu J; You J; Shi H; Xue X; Huang J; Xu L; Jiang G; Yuan L; Gong X; Luo H; Ge J; Cui Z; Zou Y
J Mol Cell Cardiol; 2018 May; 118():193-207. PubMed ID: 29626503
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 overexpression and endothelial nitric oxide synthase knock-out induce different pathological responses in the heart of male and female mice.
Vignon-Zellweger N; Relle K; Rahnenführer J; Schwab K; Hocher B; Theuring F
Life Sci; 2014 Nov; 118(2):219-25. PubMed ID: 24355292
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury.
Yang XP; Liu YH; Shesely EG; Bulagannawar M; Liu F; Carretero OA
Hypertension; 1999 Jul; 34(1):24-30. PubMed ID: 10406819
[TBL] [Abstract][Full Text] [Related]
14. The role of the RhoA/Rho-kinase signaling pathway in renal vascular reactivity in endothelial nitric oxide synthase null mice.
Williams J; Bogwu J; Oyekan A
J Hypertens; 2006 Jul; 24(7):1429-36. PubMed ID: 16794494
[TBL] [Abstract][Full Text] [Related]
15. Effect of ACE inhibitors and angiotensin II type 1 receptor antagonists on endothelial NO synthase knockout mice with heart failure.
Liu YH; Xu J; Yang XP; Yang F; Shesely E; Carretero OA
Hypertension; 2002 Feb; 39(2 Pt 2):375-81. PubMed ID: 11882576
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate receptor 2 protects against anaphylactic shock through suppression of endothelial nitric oxide synthase in mice.
Cui H; Okamoto Y; Yoshioka K; Du W; Takuwa N; Zhang W; Asano M; Shibamoto T; Takuwa Y
J Allergy Clin Immunol; 2013 Nov; 132(5):1205-1214.e9. PubMed ID: 24021572
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
[TBL] [Abstract][Full Text] [Related]
19. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
[TBL] [Abstract][Full Text] [Related]
20. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
